MEANS AND METHODS FOR IDENTIFYING AN INCREASED RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS FOR DEVELOPING RENAL MANIFESTATIONS

• 1. 一种用于检测系统性红斑狼疮(SLE)的试剂盒及其检测方法 [P] . 中国专利： CN106680411B . 2018.10.09
• 2. 一种用于检测系统性红斑狼疮（SLE)的试剂盒及其检测方法 [P] . 中国专利： CN106680411A . 2017-05-17
• 3. MEANS AND METHODS FOR IDENTIFYING AN INCREASED RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS FOR DEVELOPING RENAL MANIFESTATIONS [P] . 美国专利： US2013183662A1 . 2013-07-18

  机译： 用于确定发展性肾脏病的系统性红斑狼疮（SLE）患者风险增加的方法和方法

• 4. MEANS AND METHODS FOR IDENTIFYING AN INCREASED RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS FOR DEVELOPING RENAL MANIFESTATIONS [P] . 世界知识产权组织专利： WO2011131772A1 . 2011-10-27

  机译： 用于确定发展性肾脏病的系统性红斑狼疮（SLE）患者风险增加的方法和方法

• 5. METHODS FOR DETERMINING THE RISK OF A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT TO DEVELOP NEUROPSYCHIATRIC SYNDROMES [P] . 美国专利： US2018231565A1 . 2018-08-16

  机译： 确定系统性红斑狼疮（SLE）患者发展神经脊柱综合症的风险的方法

• 1. Spinal cord injury in patients with systemic lupus Erythematosus Clinical manifestations, imaging characteristics and treatment [J] . Yamei Tang, Fusheng Zhang, Qingyu Shen, 中国神经再生研究（英文版） . 2007,第003期
• 2. Changes of serum CRP, serum uric acid and immunoglobulin in patients with renal damage of systemic lupus erythematosus [J] . Jun Long 海南医科大学学报（英文版） . 2017,第016期
• 3. Effects of methotrexate combined with hydroxychloroquine sulfate and prednisone acetate on inflammatory response, immune function and liver and renal function in patients with systemic lupus erythematosus [J] . Jiang-Li Xia, Yong-Mei Liu, Xue-Qin Chen, 海南医科大学学报（英文版） . 2017,第022期
• 4. Changes of serum CRP, serum uric acid and immunoglobulin in patients with renal damage of systemic lupus erythematosus [J] . Jun Long 海南医科大学学报(英文版) . 2017,第016期
• 5. Profile of cardiovascular risk factors in patients with systemic Lupus Erythematosus: The CArdiovascular Risk Assessment STudy in Lupus Erythematosus (CASTLE SLE) study // Die CASTLE-SLE-Studie [J] . Fox H, Jung O, Bartel C, Journal fuer Kardiologie: Oesterreichische Zeitschrift fuer Herz-Kreislauferkrankungen . 2018,第5期
• 6. The pathogenic 16/6 idiotype in patients with silica associated systemic lupus erythematosus (SLE) and uranium miners with increased risk for development of SLE. [J] . Conrad K, Levy Y, Blank M, The Journal of rheumatology . 1998,第4期
• 7. Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE. [J] . Rossi E, Catania G, Truini M, Clinical and experimental rheumatology . 2011,第3期
• 8. Autoimmune hepatitis as the first manifestation of systemic lupus erythematosus (SLE) [C] . A. HINSBERGER, U. NEUDORF, A. BALLAUFF Falk Symposium . 2002
• 9. The effect of nutrition counseling using patient-centered counseling methods on nutrient intake in patients with systemic lupus erythematosus (SLE) [D] . Tzakas, Sotiria. 2012
• 10. Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients [O] . N MAUERMANN, Z STHOEGER, H ZINGER, 2004
• 11. AB0541 LUPUS MANIFESTATIONS IN A PATIENT WITH SPONDYLOARTHRITIS TREATED WITH TUMOUR NECROSIS FACTOR-ALPHA ANTAGONIST: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) OR DRUG-INDUCED LUPUS ERYTHEMATOSUS (DILE)? [O] . Mariam Hamid Mustapha, Syang Pyng Gan, Hazlyna Baharuddin, 2019

• 1. A Review of Systemic Lupus Erythematosus (SLE): Symptoms, Risk Factors, Treatment, and Health Related Quality of Life Issues [J] . Sarah N. Al-Gahtani . 风湿病与自身免疫疾病期刊(英文) . 2021,第4期
• 2. 手术治疗系统性红斑狼疮(SLE)患者瓣膜病变的超声表现 [C] . 杨静 ,方理刚 ,张丽华 . 中国超声医学工程学会第十二届全国超声心动图学术会议 . 2014
• 3. 甲状旁腺功能亢进症增加慢性肾脏病患者心血管疾病风险的研究进展 [A] . 何俊伶 . 2014